Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Metformin and temsirolimus may stop the growth of cancer cells by blocking some of
the enzymes needed for cell growth.
PURPOSE: This phase I trial is studying the side effects and best dose of metformin when
given together with temsirolimus in treating patients with metastatic or unresectable solid
tumor or lymphoma.